M&T Bank
CYTK icon

M&T Bank’s Cytokinetics CYTK Stock Holding History

M&T Bank’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
12,488
+1,362
+12% +$97.8K ﹤0.01% 876
2026
Q1 		$733K Sell
11,126
-74
-0.7% -$4.7K ﹤0.01% 982
2025
Q4 		$712K Buy
11,200
+5,188
+86% +$323K ﹤0.01% 982
2025
Q3 		$330K Buy
+6,012
New +$248K ﹤0.01% 1158

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M&T Bank's CYTK Position: Q2 2026 in Review

M&T Bank increased its Cytokinetics (CYTK) stake by 12% in Q2 2026, buying an estimated $97.8K and bringing the position to 12,488 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #876.

M&T Bank first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • M&T Bank held 12,488 shares of Cytokinetics worth $1.06M as of Q2 2026.
  • M&T Bank bought 1,362 Cytokinetics shares in Q2 2026, an estimated $97.8K.
  • Cytokinetics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #876 holding.
  • M&T Bank first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.